PHAI submits comments to FDA supporting reducing nicotine levels of smoked tobacco products to non-addictive levels
In response to a request for comments, PHAI urges the FDA to prioritize smoked tobacco nicotine reduction as a potentially highly effective tool to mitigate the public health cost of smoking. Please see our complete Comments (pdf).
